In addition to the well-established knowledge obtained from animal models, the central role of IgE in allergic diseases in humans has been endorsed by the emergence of anti-IgE therapy by omalizumab, effective against various allergic diseases, including asthma, chronic spontaneous urticaria, nasal polyps, and allergic rhinitis. The gene discussed is IGHE; the disease is allergic rhinitis.